Myrobalan Therapeutics
Operator of a therapeutic biotechnology company intended for developing oral neurorestorative therapies aimed at reversing key pathologies underlying brain dysfunctions and central nervous system (CNS...
Valuation
$0
Share Price
N/A
Total Raised
$43M
Last Round
N/A